Joseph Hagood

Joseph Hagood has extensive experience in the field of clinical operations. Joseph is currently serving as the Associate Director of Clinical Operations at REGENXBIO Inc. Joseph joined the company in September 2019 and continues to work in this role. Prior to their current position, they worked as a Clinical Project Manager at CTI Clinical Trial and Consulting Services from June 2018 to August 2019. Before that, they had a long tenure at Medpace where they held different roles including Clinical Trial Manager from May 2016 to June 2018, Clinical Pharmacology Unit Project Manager from June 2011 to April 2016, and Clinical Pharmacology Unit Project Manager Assistant from October 2009 to June 2011. Joseph also worked as a Clinical Regulatory Specialist at Kendle International from January 2007 to October 2009.

Joseph Hagood completed their Bachelor's of Science degree in Biology at Ohio University from 2002 to 2006. From 2014 to 2016, they pursued a Master's of Business Administration (M.B.A.) degree at the University of Cincinnati Carl H. Lindner College of Business.